Trioxaferroquines as New Hybrid Antimalarial Drugs

Citations Over TimeTop 10% of 2010 papers

Abstract

The synthesis, characterization, and antimalarial evaluation of a new series of potential antimalarial molecules, named trioxaferroquines, are reported. Trioxaferroquines are hybrid antimalarial drugs containing a 1,2,4-trioxane covalently linked to ferroquine (Fq), a synthetic ferrocenylquinoline derivative currently under clinical development. The aim was to combine, within a single structure, an iron(II) species, a 1,2,4-trioxane, as in artemisinin, and a substituted quinoline, as in chloroquine.

Related Papers

• → Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy(1996)580 cited
• → Anticancer activity of artemisinin-derived trioxanes(2006)45 cited
• → Artemisinin‐derived dimers and their antimalarial activities(2019)8 cited
• → Chemistry of artemisinin: an overview(1994)36 cited
• → Synthesis and antimalarial activities of structurally simplified 1,2,4‐trioxanes related to artemisinin(1995)35 cited